Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
astrazeneca
5
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
5
×
detroit blog main
5
×
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
pfizer
5
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
fda
cancer
clinical trials
eli lilly
merck
president trump
amgen
avexis
biogen
What
bio
drug
roundup
annual
biotech
conference
esmo
fda
news
prices
seven
alzheimer’s
approved
ash
assessed
attention
august
away
barcelona
bringing
busy
cancer
ceos
clinical
communities
companies
days
dc
december's
decisions
devices
digital
disease
drugs
epidemic
europe
european
executives
fatty
frenzied
Language
unset
Current search:
astrazeneca
×
pfizer
×
" bristol-myers squibb "
×
" detroit blog main "
×
@xconomy.com
4 years ago
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More